Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes

Clinical and Experimental Immunology

Volumn 167, Issue 2, 2012, Pages 226-234

  Lahdenpera A I ^a   Holtta V ^b   Ruohtula, T ^b   Salo, H M ^b   Orivuori, L ^b   Westerholm Ormio, M ^c   Savilahti, E ^c   Falth Magnusson K ^a   Hogberg L ^d   Ludvigsson, J ^a   Vaarala, O ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Norrköping Hospital   (Sweden)

Author keywords

Coeliac disease; FoxP3; Gluten free diet; IL 17; Type 1 diabetes

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; RETINOID RELATED ORPHAN RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CELIAC DISEASE; CELL STRAIN CACO 2; CONTROLLED STUDY; CYTOKINE RELEASE; GLUTEN FREE DIET; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE BIOPSY; LAMINA PROPRIA; MUCOSAL IMMUNITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; SMALL INTESTINE MUCOSA; SUPERNATANT; UPREGULATION;

ADENOCARCINOMA; APOPTOSIS; ATROPHY; AUTOANTIBODIES; CELIAC DISEASE; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; COLONIC NEOPLASMS; DIABETES MELLITUS, TYPE 1; DIET, GLUTEN-FREE; DUODENUM; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFANT; INTERLEUKIN-17; MALE; MICROVILLI; MUCOUS MEMBRANE; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TRANSGLUTAMINASES; UP-REGULATION;

EID: 84855767366     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04510.x     Document Type: Article

References (33)

1. Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E. Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 2003; 52:2287-95.
2. Tiittanen M, Westerholm-Ormio M, Verkasalo M, Savilahti E, Vaarala O. Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes. Clin Exp Immunol 2008; 152:498-507.
3. Auricchio R, Paparo F, Maglio M etal. In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes 2004; 53:1680-3.
4. Holm K, Maki M, Savilahti E, Lipsanen V, Laippala P, Koskimies S. Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease. Lancet 1992; 339:1500-3.
5. Arranz E, Bode J, Kingstone K, Ferguson A. Intestinal antibody pattern of coeliac disease: association with gamma/delta T cell receptor expression by intraepithelial lymphocytes, and other indices of potential coeliac disease. Gut 1994; 35:476-82.
6. Kaukinen K, Collin P, Holm K, Karvonen AL, Pikkarainen P, Maki M. Small-bowel mucosal inflammation in reticulin or gliadin antibody-positive patients without villous atrophy. Scand J Gastroenterol 1998; 33:944-9.
7. Kontakou M, Przemioslo RT, Sturgess RP etal. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. Gut 1995; 37:52-7.
8. Kontakou M, Sturgess RP, Przemioslo RT, Limb GA, Nelufer JM, Ciclitira PJ. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation. Gut 1994; 35:1037-41.
9. Nilsen EM, Jahnsen FL, Lundin KE etal. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998; 115:551-63.
10. Lahdenpera A, Ludvigsson J, Falth-Magnusson K, Hogberg L, Vaarala O. The effect of gluten-free diet on Th1-Th2-Th3-associated intestinal immune responses in celiac disease. Scand J Gastroenterol 2011; 46:538-49.
11. Castellanos-Rubio A, Santin I, Irastorza I, Castano L, Carlos Vitoria J, Ramon Bilbao J. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin. Autoimmunity 2009; 42:69-73.
12. Bodd M, Raki M, Tollefsen S etal. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol 2010; 3:594-601.
13. Ayyoub M, Deknuydt F, Raimbaud I etal. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci USA 2009; 106:8635-40.
14. Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA 2009; 106:1903-8.
15. Zhou X, Bailey-Bucktrout SL, Jeker LT etal. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10:1000-7.
16. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331:1428-36.
17. Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 2008; 24:701-6.
18. Vaarala O, Atkinson MA, Neu J. The 'perfect storm' for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008; 57:2555-62.
19. Neu J, Reverte CM, Mackey AD etal. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 2005; 40:589-95.
20. Graham S, Courtois P, Malaisse WJ, Rozing J, Scott FW, Mowat AM. Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004; 53:1437-44.
21. Honkanen J, Nieminen JK, Gao R etal. IL-17 immunity in human type 1 diabetes. J Immunol 2010; 185:1959-67.
22. Mojibian M, Chakir H, Lefebvre DE etal. Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes 2009; 58:1789-96.
23. Sapone A, Lammers KM, Mazzarella G etal. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol 2010; 152:75-80.
24. Monteleone I, Sarra M, Del Vecchio Blanco G etal. Characterization of IL-17A-producing cells in celiac disease mucosa. J Immunol 2010; 184:2211-18.
25. Fernandez S, Molina IJ, Romero P etal. Characterization of gliadin-specific Th17 cells from the mucosa of celiac disease patients. Am J Gastroenterol 2011; 106:528-38.
26. Beriou G, Costantino CM, Ashley CW etal. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009; 113:4240-9.
27. Ye J, Su X, Hsueh EC etal. Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-gamma+ and FOXP3+ T cells with potent suppressive function. Eur J Immunol 2011; 41:936-51.
28. Mazzarella G, Stefanile R, Camarca A etal. Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. Gastroenterology 2008; 134:1017-27.
29. Emamaullee JA, Davis J, Merani S etal. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009; 58:1302-11.
30. Lau K, Benitez P, Ardissone A etal. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6·2-mediated Th17 bias. J Immunol 2011; 186:3538-46.
31. Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol 2010; 30:196-203.
32. Arif S, Moore F, Marks K etal. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated {beta}-cell death. Diabetes 2011; 60:2112-19.
33. Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hanninen A. Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 2010; 59:2237-46.